Sorafenib promotes Treg cell differentiation to compromise its efficacy via VEGFR/AKT/Foxo1 signaling in hepatocellular carcinoma.
Shen Y, Wang H, Ma Z, Hao M, Wang S, Li J, Fang Y, Yu L, Huang Y, Wang C, Xiang J, Cai Z, Wang J, Jin H, Zhou J, Guo J, Ying P, Wang X.
Shen Y, et al. Among authors: jin h.
Cell Mol Gastroenterol Hepatol. 2024 Dec 30:101454. doi: 10.1016/j.jcmgh.2024.101454. Online ahead of print.
Cell Mol Gastroenterol Hepatol. 2024.
PMID: 39743020